News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
794,691 Results
Type
Article (57771)
Company Profile (507)
Press Release (736395)
Multimedia
Podcasts (183)
Webinars (29)
Section
Business (219830)
Career Advice (2912)
Deals (37972)
Drug Delivery (160)
Drug Development (87758)
Employer Resources (191)
FDA (17992)
Job Trends (16144)
News (374880)
Policy (37166)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2910)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (173)
Alliances (53886)
ALS (207)
Alzheimer's disease (1877)
Antibody-drug conjugate (ADC) (410)
Approvals (18221)
Artificial intelligence (672)
Autoimmune disease (246)
Automation (52)
Bankruptcy (397)
Best Places to Work (12211)
BIOSECURE Act (23)
Biosimilars (217)
Biotechnology (350)
Bladder cancer (185)
Brain cancer (71)
Breast cancer (717)
Cancer (5606)
Cardiovascular disease (501)
Career advice (2468)
Career pathing (45)
CAR-T (328)
CDC (71)
Celiac Disease (2)
Cell therapy (884)
Cervical cancer (42)
Clinical research (74991)
Collaboration (2059)
Company closure (6)
Compensation (1314)
Complete response letters (90)
COVID-19 (2991)
CRISPR (110)
C-suite (1048)
Cystic fibrosis (160)
Data (7220)
Decentralized trials (3)
Denatured (59)
Depression (174)
Dermatology (59)
Diabetes (587)
Diagnostics (7189)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (331)
Drug pricing (237)
Drug shortages (35)
Duchenne muscular dystrophy (286)
Earnings (95648)
Editorial (71)
Employer branding (22)
Employer resources (163)
Events (128069)
Executive appointments (1101)
FDA (21531)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1711)
Gene editing (235)
Generative AI (57)
Gene therapy (736)
GLP-1 (1196)
Government (5241)
Grass and pollen (8)
Guidances (399)
Healthcare (20112)
HIV (79)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (327)
Immuno-oncology (91)
Indications (158)
Infectious disease (3335)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (137)
Intellectual property (283)
Interviews (530)
IPO (17453)
IRA (60)
Job creations (4286)
Job search strategy (2026)
JPM (71)
Kidney cancer (19)
Labor market (99)
Layoffs (657)
Leadership (44)
Legal (9295)
Liver cancer (105)
Longevity (28)
Lung cancer (755)
Lymphoma (417)
Machine learning (54)
Management (64)
Manufacturing (988)
MASH (194)
Medical device (14713)
Medtech (14793)
Mergers & acquisitions (21696)
Metabolic disorders (1581)
mRNA (213)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (432)
Neuropsychiatric disorders (115)
Neuroscience (3394)
Neurotech (2)
NextGen: Class of 2026 (7199)
Non-profit (4870)
Now hiring (74)
Obesity (776)
Opinion (334)
Ovarian cancer (190)
Pain (244)
Pancreatic cancer (266)
Parkinson's disease (364)
Partnered (34)
Patents (580)
Patient recruitment (615)
Peanut (65)
People (63996)
Pharmaceutical (88)
Pharmacy benefit managers (36)
Phase 1 (23351)
Phase 2 (32806)
Phase 3 (24620)
Pipeline (7295)
Policy (365)
Postmarket research (2980)
Preclinical (10055)
Press Release (69)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (327)
Rare diseases (1110)
Real estate (6646)
Recruiting (74)
Regulatory (27922)
Reports (61)
Research institute (2674)
Resumes & cover letters (476)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (178)
Series A (288)
Series B (213)
Service/supplier (14)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (181)
Sponsored (52)
Startups (4037)
State (2)
Stomach cancer (21)
Supply chain (126)
Tariffs (102)
The Weekly (121)
Vaccines (1217)
Venture capital (111)
Weight loss (527)
Women's health (115)
Worklife (23)
Date
Last 7 days (668)
Last 30 days (2570)
Last 365 days (31754)
2026 (8463)
2025 (32161)
2024 (37294)
2023 (42028)
2022 (53386)
2021 (58037)
2020 (56566)
2019 (49523)
2018 (37473)
2017 (35237)
2016 (35509)
2015 (41361)
2014 (35598)
2013 (30494)
2012 (32663)
2011 (33194)
2010 (31472)
Location
Africa (934)
Alabama (98)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (45173)
Australia (7532)
California (12677)
Canada (3565)
China (1318)
Colorado (538)
Connecticut (554)
Delaware (377)
Europe (102057)
Florida (1893)
Georgia (406)
Hawaii (4)
Idaho (66)
Illinois (1032)
India (84)
Indiana (578)
Iowa (24)
Japan (501)
Kansas (135)
Kentucky (48)
Louisiana (41)
Maine (84)
Maryland (1556)
Massachusetts (9216)
Michigan (366)
Minnesota (706)
Mississippi (7)
Missouri (150)
Montana (36)
Nebraska (30)
Nevada (138)
New Hampshire (89)
New Jersey (3416)
New Mexico (31)
New York (3361)
North Carolina (1706)
North Dakota (10)
Northern California (6211)
Ohio (387)
Oklahoma (24)
Oregon (46)
Pennsylvania (2537)
Puerto Rico (27)
Rhode Island (51)
South America (1351)
South Carolina (78)
South Dakota (1)
Southern California (4965)
Tennessee (203)
Texas (2003)
United States (45348)
Utah (380)
Vermont (1)
Virginia (309)
Washington D.C. (86)
Washington State (1033)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
794,691 Results for "y s therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 12, 2026
·
9 min read
Press Releases
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
March 11, 2026
·
3 min read
Press Releases
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
January 12, 2026
·
11 min read
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
August 6, 2025
·
15 min read
Press Releases
Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.
April 1, 2026
·
4 min read
Press Releases
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering
March 25, 2026
·
5 min read
Press Releases
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
March 10, 2026
·
5 min read
Press Releases
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering
March 24, 2026
·
5 min read
Press Releases
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 2, 2026
·
4 min read
1 of 79,470
Next
